Synonyms: | |
Status: | Phase 3 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
ATC: | L01XX58 |
UNII: | 71596A9R13 |
InChI Key | FBKMWOJEPMPVTQ-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C11H13BrFN7O4S |
Molecular Weight | 438.24 |
AlogP | 0.42 |
Hydrogen Bond Acceptor | 8.0 |
Hydrogen Bond Donor | 5.0 |
Number of Rotational Bond | 7.0 |
Polar Surface Area | 167.76 |
Molecular species | ACID |
Aromatic Rings | 2.0 |
Heavy Atoms | 25.0 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Indoleamine 2,3-dioxygenase inhibitor | PubMed |
Primary Target | |
---|---|
indoleamine 2,3-dioxygenase 1 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Oxidoreductase
|
8-13 | 3-125 | 3460 | 21700-21700 | 92-101 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Lung Neoplasms | 3 | D008175 | ClinicalTrials |
Melanoma | 3 | D008545 | ClinicalTrials |
Melanoma | 3 | D008545 | ClinicalTrials |
Head and Neck Neoplasms | 3 | D006258 | ClinicalTrials |
Urogenital Neoplasms | 3 | D014565 | ClinicalTrials |
Carcinoma, Renal Cell | 3 | D002292 | ClinicalTrials |
Myelodysplastic Syndromes | 2 | D009190 | ClinicalTrials |
Carcinoma, Squamous Cell | 2 | D002294 | ClinicalTrials |
Sarcoma | 2 | D012509 | ClinicalTrials |
Small Cell Lung Carcinoma | 2 | D055752 | ClinicalTrials |
Gastrointestinal Stromal Tumors | 2 | D046152 | ClinicalTrials |
Glioblastoma | 2 | D005909 | ClinicalTrials |
Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
Carcinoma, Pancreatic Ductal | 2 | D021441 | ClinicalTrials |
Hereditary Breast and Ovarian Cancer Syndrome | 2 | D061325 | ClinicalTrials |
Urinary Bladder Neoplasms | 2 | D001749 | ClinicalTrials |
Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
Urinary Bladder Neoplasms | 2 | D001749 | ClinicalTrials |
Endometrial Neoplasms | 2 | D016889 | ClinicalTrials |
Thymoma | 2 | D013945 | ClinicalTrials |
Endometrial Neoplasms | 2 | D016889 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
Fallopian Tube Neoplasms | 1 | D005185 | ClinicalTrials |
Rectal Neoplasms | 1 | D012004 | ClinicalTrials |
Hematologic Neoplasms | 1 | D019337 | ClinicalTrials |
Prostatic Neoplasms | 1 | D011471 | ClinicalTrials |
Leukemia, Myeloid, Acute | 1 | D015470 | ClinicalTrials |
Peritoneal Neoplasms | 1 | D010534 | ClinicalTrials |
Fallopian Tube Neoplasms | 1 | D005185 | ClinicalTrials |
Lymphoma | 1 | D008223 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 1204669-58-8 |
ChEMBL | CHEMBL3545369 |
DrugBank | DB11717 |
FDA SRS | 71596A9R13 |
Guide to Pharmacology | 8221 |
PDB | BBJ |
PubChem | 135564890 |
SureChEMBL | SCHEMBL18823200 |
ZINC | ZINC000113208009 |